Last updated: April 2026
A sterile barrier system is only sterile if the package seal held through manufacturing, shipping, storage, and shelf life. Any one of those stages can introduce a channel defect, a pinhole, or a closure failure that invalidates sterility without anyone noticing until a patient is affected. Medical device packaging validation exists to find those failures before product reaches the hospital.
Medical device packaging is governed by ISO 11607, supported by USP <1207> for sterile drug crossover, and validated through a defined set of ASTM test methods. This guide covers what medical device packaging has to do, which standards and tests apply, and how to build a validation program that stands up to audit scrutiny without guesswork. FlexPak’s role in that program is specific: testing. FlexPak does not manufacture packaging, sterile barrier systems, or the gas-analysis or RFID systems sometimes discussed in medical packaging industry coverage. FlexPak builds the equipment that verifies package integrity against the ASTM standards that matter.
What Is Medical Device Packaging?
Medical device packaging is the system of materials and closures that protects a medical device from contamination, damage, and environmental exposure from production through point of use. For terminally sterilized devices, the packaging serves a second function: it is the sterile barrier system that maintains sterility until the device reaches the clinical setting. Both functions are validated against ISO 11607 and supported by ASTM test methods.
Medical device packaging is not a single format. It includes peel pouches, Tyvek lidded trays, rigid thermoformed blisters, pre-filled syringe containers, and sealed cases for implants and instruments. Different formats use different materials (Tyvek, foil, polyester, HDPE), different closure methods (heat seals, lug closures, threaded caps), and different sterilization routes (gamma, ethylene oxide, steam). Each combination has implications for which test methods apply.
What Medical Device Packaging Has to Do
Medical device packaging has two jobs, and both of them get tested separately. Understanding the distinction is the foundation of a validation program.
Maintain the sterile barrier. The package has to prevent microbial ingress from the moment sterilization ends until the device is opened. Any breach in the sterile barrier during manufacturing, distribution, or storage invalidates sterility. The failures that matter here are seal channel defects, pinholes in the film, and closure failures. They are invisible to visual inspection and often pass seal strength testing. Integrity testing is what catches them.
Survive distribution. Packages experience pressure differentials during air shipment, vibration during transport, temperature swings through cold chain, and compression during stacking. A seal that holds fine at the plant can fail during distribution. ISO 11607 requires validation against these distribution hazards, typically through conditioning tests like altitude simulation followed by integrity testing.
What failure actually looks like in medical device packaging:
- Channel defects at the seal corner from wrinkles, misalignment, or contamination in the seal zone
- Pinholes in Tyvek or film from handling, flex-cracking, or material defects
- Closure failures on rigid containers from inadequate torque or worn threads
- Seal bar drift producing marginal seals that pass initial inspection and fail under distribution stress
- Tyvek breaches that compromise the porous barrier without any visible indication
For a deeper look at the sterile barrier system concept, see our sterile barrier system testing guide.
The Standards That Govern Medical Device Packaging
Medical device packaging sits inside a layered regulatory framework. Knowing which standard does what saves significant validation work.
ISO 11607-1 and ISO 11607-2 (primary standard). ISO 11607 is the globally recognized standard for packaging of terminally sterilized medical devices. ISO 11607-1 covers requirements for the sterile barrier system itself: materials, design, and performance. ISO 11607-2 covers validation requirements for forming, sealing, and assembly processes. Together, they require performance qualification that includes integrity testing, distribution hazard testing, and shelf life validation. For a deeper look at ISO 11607-1, see our ISO 11607 guide.
USP <1207> (for sterile drug-device combination products). USP <1207> is the pharmacopeial framework for package integrity evaluation of sterile products. It categorizes test methods as deterministic (quantitative, reproducible) or probabilistic (qualitative, visual), and favors deterministic methods like vacuum decay for primary CCIT validation of sterile products. Probabilistic methods including F2096 bubble emission may serve as practical complements for gross leak detection and routine monitoring. USP <1207> applies most directly to drug-device combination products and pre-filled syringes. For medical device programs specifically, see our CCIT for sterile products guide.
ASTM test methods (the actual tests). ASTM standards define the specific test procedures validation programs use. The ones that apply most often to medical device packaging are F2096 (internal pressurization), D3078 (bubble emission), D6653 (altitude simulation conditioning), F88 (seal strength), and F2338 (vacuum decay). Each one catches a different kind of failure in a different kind of package.
FDA guidance. FDA 21 CFR Part 820 establishes Quality System Regulation requirements for medical devices. As of February 2026, 21 CFR Part 820 has been updated under the Quality Management System Regulation (QMSR) final rule to incorporate ISO 13485 by reference. FDA guidance documents emphasize package integrity as part of design validation and process validation. FDA does not mandate specific test methods, but expects validated and documented methods appropriate to the device and packaging format.
The 5 Tests That Validate Medical Device Packaging
Five ASTM test methods cover most medical device packaging validation programs. Each one has a specific purpose and fits a specific place in the ISO 11607 framework.
| Test | ASTM Standard | Purpose | Where It Fits in ISO 11607 | Destructive? |
|---|---|---|---|---|
| Internal Pressurization | F2096 | Gross leak detection in trays, pouches, and Tyvek packaging | Sterile barrier integrity testing | Yes (puncture required) |
| Bubble Emission | D3078 | Gross leak detection in flexible packages with headspace | Sterile barrier integrity for non-porous flexible formats | No |
| Altitude Simulation | D6653 | Conditioning for distribution hazard validation | Distribution qualification, pair with detection method | No |
| Seal Strength | F88 | Peel force measurement for heat seals | Process validation for sealing equipment | Yes |
| Vacuum Decay | F2338 | Nondestructive leak detection with validated sensitivity per container type | Primary CCIT for rigid sterile containers | No |
Internal pressurization (F2096). F2096 is the primary bubble test for medical device packaging. The package is inflated from the inside via a needle through a septum while submerged in water, and bubbles at failure points reveal the defect location. It handles Tyvek and other porous barrier materials that D3078 cannot reliably test. The ASTM F2096 standard states method sensitivity is down to 250 µm with approximately 81% probability, based on interlaboratory round-robin data. Detection at that size is not guaranteed. Roughly 1 in 5 specimens in the round-robin were not detected. F2096 is destructive because the package must be punctured. For implementation specifics, see our ASTM F2096 guide.
Bubble emission (D3078). D3078 handles flexible medical packaging with headspace that doesn’t require internal pressurization. The package is submerged in water inside a vacuum chamber, vacuum is drawn, and escaping gas produces visible bubbles at defect sites. D3078 is designed to detect gross leaks. Actual sensitivity depends on vacuum level, headspace volume, product type, and packaging material. No universal micron figure applies. For flexible medical packaging with adequate headspace, D3078 is fast (around 30 seconds per cycle) and nondestructive.
Altitude simulation (D6653). Medical devices shipped by air experience pressure differentials that can open marginal seals. D6653 is a conditioning method that recreates those pressure drops in a controlled chamber. D6653 does not detect leaks on its own. It stresses the package, and you then pair it with a detection method like D3078 or F2096 to identify what failed. For ISO 11607 distribution qualification, D6653 is commonly paired with an integrity detection method.
Seal strength (F88). F88 measures the force required to peel a seal apart, typically through T-peel or 180-degree peel test configurations. It is a strength test, not an integrity test. A seal can pass F88 with strong, consistent numbers and still have a channel defect that allows microbial ingress. F88 supports process validation for sealing equipment by catching seal bar drift, temperature issues, and pressure changes across production. Complete validation programs run F88 alongside F2096 or D3078. For specifics, see our ASTM F88 guide.
Vacuum decay (F2338). F2338 is a deterministic, nondestructive method commonly used for rigid sterile containers, glass syringes, and other nonporous formats where USP <1207> favors deterministic validation. Sensitivity is validated per package type. For rigid nonporous bottles, detection is validated down to 5 µm at –500 mbar. For other formats, sensitivity must be validated under defined conditions. F2338 does not pinpoint leak location, which is one reason F2096 often complements it for troubleshooting.
How to Build a Medical Device Packaging Validation Program
ISO 11607-2 requires documented validation of packaging processes. Here is the practical framework.
1. Define the sterile barrier system. Identify every material and closure element that contributes to maintaining sterility. This is the scope of what validation will cover.
2. Write the validation protocol. Document the test methods, acceptance criteria, sample sizes, and environmental conditions. ISO 11607-2 expects validation protocols to address sterile barrier integrity, distribution hazards, and shelf life. Reference the specific ASTM standards (F2096, D3078, D6653, F88, F2338) you will use and why.
3. Run Installation Qualification (IQ). Document that testing equipment is installed correctly, connected properly, and operating per manufacturer specifications. For FlexPak equipment, this includes compressed air supply (75 psig at 13 SCFM for the core unit), recording the Facility Vacuum Offset, and verifying the chamber fills and drains correctly.
4. Run Operational Qualification (OQ). Verify the equipment performs to specification under defined operating conditions. For D3078 testing, this means confirming the system reaches 27 inHg (adjusted for Facility Vacuum Offset). For F2096, it means confirming the FPIPA regulator holds pressure at the target level.
5. Run Performance Qualification (PQ). Test actual packaged product per the validation protocol. Increase vacuum or pressure setpoints on control samples with known defects until the method reliably detects them. This establishes the method’s performance boundary for your specific packaging.
6. Document, approve, and schedule requalification. Validation documentation becomes the artifact auditors and regulators review. Plan for requalification after any change to packaging materials, sealing equipment, sterilization process, or testing equipment. For ISO 11607-2 implementation specifics, see our ISO 11607-2 guide.
How FlexPak Supports Medical Device Packaging Testing
FlexPak does not manufacture medical device packaging. FlexPak builds the equipment that validates medical device packaging integrity against ASTM standards.
For F2096 internal pressurization testing (the primary gross leak method for Tyvek, porous barriers, and medical pouches), the FlexPak Internal Pressurization Assembly (FPIPA) attaches to any standard FlexPak Leak Detector. It includes the needle, septa, pressure regulator, and low-pressure gauge needed for F2096 testing, with pressure adjustable from 0 to 20 inches of water. For programs that do not already have a base unit, the FPIPA is also available as a standalone.
For D3078 bubble emission testing on flexible medical packaging with headspace, the core FlexPak Leak Detector runs the test in around 30 seconds per cycle with visual confirmation of leak location.
For D6653 altitude simulation as part of ISO 11607 distribution qualification, the same core unit runs altitude conditioning. The Fully Automatic Controller (FPFA-T) supports up to 26 altitude simulation recipes with configurable ascent/descent rates and cruise altitude hold times.
For vacuum-sealed medical components (pre-filled syringes, vacuum-pouched implants), the VAC Attachment introduces a controlled air shot before D3078 testing so the package can form a meaningful pressure differential.
For data logging and audit trail documentation, the FPFA-T logs test results with lot number, recipe, operator, and pass/fail status to an SD card formatted for the FlexPak system.
For F2338 vacuum decay testing, FlexPak does not manufacture vacuum decay equipment. If your validation protocol requires F2338 as the primary deterministic method under USP <1207>, you will need a vacuum decay unit from a different vendor. FlexPak equipment pairs naturally with that workflow for routine monitoring and defect troubleshooting via F2096 or D3078.
See which FlexPak unit fits your medical packaging or explore the FPIPA attachment for F2096 testing specifically.
Frequently Asked Questions
What is medical device packaging?
Medical device packaging is the system of materials and closures that protects a medical device from contamination, damage, and environmental exposure from production through point of use. For terminally sterilized devices, it functions as the sterile barrier system that maintains sterility until clinical use. It is governed primarily by ISO 11607 and validated through ASTM test methods including F2096, D3078, D6653, F88, and F2338.
What ASTM standards apply to medical device packaging?
The ASTM standards most commonly applied to medical device packaging are F2096 (internal pressurization bubble test for Tyvek and porous barriers), D3078 (bubble emission for flexible packages with headspace), D6653 (altitude simulation for distribution qualification), F88 (seal strength for process validation), and F2338 (vacuum decay for rigid containers requiring deterministic validation). Method selection depends on packaging format and the specific requirements of ISO 11607 performance qualification.
Does ISO 11607 require ASTM F2096?
ISO 11607 does not mandate any specific ASTM test method. It requires performance qualification of sterile barrier integrity using validated methods appropriate to the packaging format, with test sensitivity demonstrated for the specific package being validated. F2096 is commonly selected because it handles Tyvek and porous barrier materials that other bubble tests cannot reliably evaluate, and because its 81% detection probability at 250 µm is documented by ASTM round-robin data. Many programs pair F2096 with a deterministic method like F2338 for primary CCIT validation when USP <1207> applies.
What is the difference between the sterile barrier system and protective packaging?
The sterile barrier system (SBS) is the part of the packaging that maintains sterility. It includes the materials and closures that prevent microbial ingress. Protective packaging surrounds the SBS to protect it from physical damage during distribution. Under ISO 11607, the SBS is validated against sterility requirements (integrity testing), while protective packaging is validated against distribution hazards (shock, vibration, pressure, temperature).
Your Medical Device Packaging Is Only as Good as Its Validation
Medical device packaging has to maintain sterility and survive distribution. ISO 11607 defines what validation looks like. ASTM test methods define how the validation gets done. F2096 handles Tyvek and porous barriers. D3078 handles flexible formats with headspace. D6653 conditions packages for distribution qualification. F88 catches sealing process drift. F2338 supports deterministic CCIT under USP <1207>.
FlexPak builds testing equipment for F2096, D3078, and D6653 on a single platform, with data logging for audit trail documentation and FPIPA attachment for medical-specific F2096 testing.
If you are building or auditing a medical device packaging validation program, see which FlexPak unit fits your medical packaging or explore the FPIPA attachment for F2096 capability specifically.